Sort
30,917 grants matching “tumor microenvironment”
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs
$495,520Sana D Karam · University Of Colorado Denver · R01 · FY2024 · DE
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
$495,498Russell S Taichman · University Of Michigan At Ann Arbor · U54 · FY2014 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$495,460Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$495,420Bin Zhang · Northwestern University At Chicago · R01 · FY2020 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$495,372Edgar G. Engleman · Stanford University · R01 · FY2025 · CA
NASH-associated macrophages: regulation and role in disease pathogenesis
$495,325Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$495,221Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2023 · CA
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$495,221Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Image-guided radiation-induced permeability (IGRIP) for IGDD
$495,216Stephen J. Kron · University Of Chicago · R01 · FY2016 · CA
Artemin overexpression in oral cancer pain and carcinogenesis
$495,216Donna G Albertson · New York University · R01 · FY2019 · CA
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
$495,171Daniel J Brat · Northwestern University At Chicago · R01 · FY2023 · CA
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
$495,169Daniel J Brat · Northwestern University At Chicago · R01 · FY2022 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$495,129Dai Fukumura · Massachusetts General Hospital · R01 · FY2017 · CA
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$495,105Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2025 · CA
Gain-of-function complement activators as a new class of immunotherapeutic molecules
$495,105Ruben Martinez Barricarte · Vanderbilt University Medical Center · R01 · FY2023 · CA
Administrative Core
$495,090Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$494,990James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Clinical trials employing cancer vaccine combination therapies
$494,990James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer
$494,907Sergei I Grivennikov · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA
Microenvironmental Control of Capillary Morphogenesis
$494,906Andrew J Putnam · University Of Michigan At Ann Arbor · R01 · FY2024 · HL
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
$494,886Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Transcriptomic origins of cancer
$494,875Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$494,864Zena Werb · University Of California, San Francisco · R01 · FY2017 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$494,864Zena Werb · University Of California, San Francisco · R01 · FY2016 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$494,864Zena Werb · University Of California, San Francisco · R01 · FY2015 · CA